Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs rabeprazole dual therapy for Helicobacter pylori eradication
ChiCTR2300077528Phase 4Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Helicobacter pylori infection comparing Vonoprazan + amoxicillin with Rabeprazole + amoxicillin (2 arms). Primary endpoints: Helicobacter pylori eradication rate and Patient compliance. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
vonoprazanrabeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300077528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077528.